Table 7.
Formulation | Survival (%) | Enhancement ratio | P -value * |
---|---|---|---|
PLGA-SPION | 93.1±1.2 | - | - |
Gem | 50.0±0.0 | 1.00 | - |
PLGA-Gem | 32.7±1.1 | 1.53 | 0.015 |
SPION-PLGA-Gem | 26.2±2.3 | 1.89 | 0.006 |
P-values are calculated compared to Gemcitabine group
Formulation | Survival (%) | Enhancement ratio | P -value * |
---|---|---|---|
PLGA-SPION | 93.1±1.2 | - | - |
Gem | 50.0±0.0 | 1.00 | - |
PLGA-Gem | 32.7±1.1 | 1.53 | 0.015 |
SPION-PLGA-Gem | 26.2±2.3 | 1.89 | 0.006 |
P-values are calculated compared to Gemcitabine group